Comparative responsiveness of Parkinson's disease scales to change over time

Movement Disorders

Volumn 24, Issue 6, 2009, Pages 813-818

  Schrag, Anette ^a,b   Spottke, Annika ^c   Quinn, Niall Patrick ^b   Dodel, Richard ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BONN   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hr QoL; Parkinson's disease; Responsiveness; Scales; UPDRS

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC ACCURACY; DISABILITY; DISEASE SEVERITY; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PARKINSON DISEASE QUALITY OF LIFE; PARKINSON DISEASE QUALITY OF LIFE 39; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCHWAB AND ENGLAND SCALE; SELF CONCEPT; STANDARDISED EFFECT SIZE; STANDARDISED RESPONSE MEAN; STANDARDIZATION; STUDENT T TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 67651151388     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22438     Document Type: Article

References (29)

1. Fahn S, Elton RL; members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Florham Park, NJ: MacMillan Healthcare Information; 1987.
2. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJDIML, editor. Third symposium on Parkinson's disease. Edinburgh: Livingstone; 1969. p 152-157.
3. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
4. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002;72:241-248.
5. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000;53:459-468.
6. Gibb WR, Lees AJ. The signi.cance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989;15:27-44.
7. Spottke AE, Reuter M, Machat O, et al. Cost of illness and its predictors for Parkinson's disease in Germany. Pharmacoeconomics 2005;23:817-836.
8. Schrag A, Ben Shlomo Y, Quinn NP. Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 2000;321:21-22.
9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984;40: 1365-1367.
12. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-S14.
13. de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
14. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
15. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Youngversus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord 2003;18:1250-1256.
16. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984;40: 1365-1367.
17. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-S14.
18. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
19. Martinez-Martin P, Prieto L, Forjaz MJ. Longitudinal metric properties of disability rating scales for Parkinson's disease. Value Health 2006;9:386-393.
20. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press; 1977.
21. Martinez-Martin P, Carod-Artal FJ, da Silveira RL, et al. Longitudinal psychometric attributes, responsiveness, and importance of change: an approach using the SCOPA-Psychosocial questionnaire. Mov Disord 2008;23:1516-1523.
22. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
23. Hagell P, Crabb L, Pogarell O, et al. Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Mov Disord 2000;15:224-229.
24. de Bie RM, Schuurman PR, Bosch DA, de Haan RJ, Schmand B, Speelman JD. Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients. J Neurol Neurosurg Psychiatry 2001;71:375-382.
25. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
26. Olanow CW, Kieburtz K, Stern M, et al. Double-blind, placebocontrolled study of entacapone in levodopa-treated patients with stable Parkinson disease. Arch Neurol 2004;61:1563-1568.
27. Koller W, Lees A, Doder M, Hely M. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations. Mov Disord 2001;16:858-866.
28. Reichmann H, Boas J, Macmahon D, Myllyla V, Hakala A, Reinikainen K. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations. Acta Neurol Scand 2005; 111:21-28.
29. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-1028.